The Arterial Thrombosis market size is USD 5.6 Bn in 2026.
The Arterial Thrombosis market is projected to grow at a CAGR of 10% by 2033, reaching USD 10.6 Bn.
The Arterial Thrombosis market growth drivers include advancements in oral anticoagulants, rising incidence of cardiovascular disorders, and increasing government healthcare expenditure.
North America is a dominating region for the Arterial Thrombosis market.
Pfizer Inc., Bristol-Myers Squibb Company, Bayer AG, Johnson & Johnson, and Sanofi S.A. are some leading industry players in the Arterial Thrombosis market.